We are live on ! Find out more
ACP

Aveo Capital Partners Portfolio holdings

AUM $601M
1-Year Est. Return 5.92%
This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+5.92%
3 Year Est. Return
+19.07%
5 Year Est. Return
+62.74%
10 Year Est. Return
AUM
$216M
AUM Growth
+$16.2M
Cap. Flow
+$2.86M
Cap. Flow %
1.32%
Top 10 Hldgs %
35.62%
Holding
175
New
46
Increased
71
Reduced
42
Closed
8
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWI icon
151
iShares MSCI Italy ETF
EWI
$1.01B
$212K 0.1%
+7,631
New +$202K
IOO icon
152
iShares Global 100 ETF
IOO
$8.93B
$211K 0.1%
+4,427
New +$202K
IHI icon
153
iShares US Medical Devices ETF
IHI
$3.13B
$210K 0.1%
5,454
-73,926
-93% -$2.68M
PG icon
154
Procter & Gamble
PG
$336B
$208K 0.1%
+2,004
New +$195K
SCJ icon
155
iShares MSCI Japan Small-Cap ETF
SCJ
$253M
$208K 0.1%
+2,948
New +$204K
META icon
156
Meta Platforms (Facebook)
META
$1.42T
$206K 0.1%
+1,233
New +$196K
SPSM icon
157
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.1B
$206K 0.1%
6,807
-7,902
-54% -$235K
ARLP icon
158
Alliance Resource Partners
ARLP
$3.34B
$203K 0.09%
+9,976
New +$193K
EWY icon
159
iShares MSCI South Korea ETF
EWY
$21.9B
$202K 0.09%
+3,319
New +$206K
WMT icon
160
Walmart Inc
WMT
$885B
$202K 0.09%
+6,201
New +$201K
MRK icon
161
Merck
MRK
$322B
$201K 0.09%
+2,531
New +$189K
CWEN icon
162
Clearway Energy Class C
CWEN
$4.94B
$162K 0.07%
+10,725
New +$161K
CVS icon
163
CVS Health
CVS
$133B
$139K 0.06%
+2,582
New +$159K
ENDP
164
DELISTED
Endo International plc
ENDP
$97K 0.04%
12,083
-300
-2% -$2.82K
VRDN icon
165
Viridian Therapeutics
VRDN
$2.09B
$47K 0.02%
1,115
ORKA
166
Oruka Therapeutics
ORKA
$5.82B
$35K 0.02%
432
CVS icon
167
CALL
CVS Health
CVS
$133B
$26K 0.01%
+8,000
New +$494K
ABBV icon
168
AbbVie
ABBV
$443B
-2,465
Closed -$227K
BIL icon
169
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47.1B
-4,292
Closed -$393K
EWZ icon
170
iShares MSCI Brazil ETF
EWZ
$9.28B
-5,408
Closed -$207K
HYLB icon
171
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.52B
-68,915
Closed -$2.58M
IGSB icon
172
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
-5,138
Closed -$265K
QQQ icon
173
Invesco QQQ Trust
QQQ
$453B
-1,946
Closed -$300K
SHV icon
174
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
-2,338
Closed -$258K
SPIB icon
175
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
-76,959
Closed -$2.54M

Similar funds

Aveo Capital Partners's Q1 2019 Portfolio in Review

As of Q1 2019, Aveo Capital Partners held 175 positions worth $216M, up 8.1% from $200M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Aveo Capital Partners's Q1 2019 filing shows 46 new, 71 increased, 42 reduced and 8 closed positions. Its largest new stake was iShares Morningstar Multi-Asset Income ETF: 197,580 shares worth $4.88M. The largest sale was QuantX Risk Managed Growth ETF, an estimated $19.9M.

By sector, the portfolio is most concentrated in Energy at 3% of assets, up from 2% a quarter earlier, followed by Communication Services and Technology.

  • Aveo Capital Partners's largest Q1 2019 buy was iShares Morningstar Multi-Asset Income ETF: 197,580 shares worth $4.88M.
  • Aveo Capital Partners added most to iShares 20+ Year Treasury Bond ETF in Q1 2019, an estimated $2.4M increase.
  • Aveo Capital Partners's biggest Q1 2019 reduction was QuantX Risk Managed Growth ETF, cutting an estimated $19.9M.
  • Aveo Capital Partners fully exited Xtrackers USD High Yield Corporate Bond ETF in Q1 2019, selling an estimated $2.58M.
  • Aveo Capital Partners's ten largest holdings make up 36% of its $216M portfolio in Q1 2019.
  • Aveo Capital Partners opened 46 new positions and closed 8 in Q1 2019.
  • Aveo Capital Partners's portfolio value rose 8.1% quarter-over-quarter to $216M.

Based on Aveo Capital Partners's 13F filing for Q1 2019, filed 7 May 2019.